Salesforce Gives Lukewarm Outlook That Fuels Disruption Fear

Salesforce’s fiscal Q2 revenue outlook of about $11.3 billion came in slightly below the $11.4 billion consensus, while fiscal Q1 remaining performance obligations of $67.9 billion also missed the $68.9 billion estimate. The quarter itself was strong, with revenue up 13% to $11.1 billion and adjusted EPS of $3.88 beating the $3.13 estimate, but investors remain focused on whether AI products like Agentforce can drive broader growth. Shares fell about 2% in extended trading and are down roughly 33% year to date.

Analysis

The market is reacting less to the quarter than to the signal that AI monetization is not yet powerful enough to offset baseline software deceleration. That matters because the sell-side has been willing to underwrite “AI as a second-half accelerant” across application software; this print weakens that bridge and likely forces a broader reset of FY2H expectations across names whose valuation still embeds durable mid-teens growth. The immediate second-order effect is on relative multiples: even modest guidance misses can keep compressing long-duration SaaS names as investors demand proof of net-new demand rather than just usage metrics.

The competitive read-through is more important than the headline guidance miss. If the category leader is struggling to convert agentic AI activity into near-term bookings, then smaller vendors selling AI copilots or workflow automation likely face longer sales cycles and harder ROI scrutiny, especially in customer support and front-office workflow. That creates a bifurcation: vendors with clear labor-replacement economics and vertical specificity can outperform, while broad platform names risk seeing AI uplift accrue first to hyperscalers and model providers rather than application-layer incumbents.

There is also a positioning angle: the stock is already in a drawdown, so the first reaction may be underwhelming unless the next quarter shows a visible inflection in RPO and consumption conversion. The contrarian view is that the market may be underestimating how quickly AI attach can improve once enterprise procurement shifts from pilots to standardized deployments, but that is a 6-12 month story, not a near-term trading catalyst. For now, the burden of proof is on management to show that AI usage translates into higher seat expansion, lower churn, or stronger cross-sell — otherwise the multiple remains vulnerable to further compression.

Key Decisions for Investors

• Short CRM into strength over the next 1-3 sessions; risk/reward favors fading any relief bounce because the near-term catalyst path is weak and the stock remains vulnerable to another 5-8% de-rating if guidance skepticism spreads.
• Pair trade: long INFA / short CRM for 1-2 months. INFA has a cleaner incremental benefit from data-layer AI spending, while CRM is carrying the burden of proving monetization; downside on the short leg should be buffered if the market keeps rewarding data infrastructure over application-layer narratives.
• Reduce/avoid long exposure to NOW and ADBE for the next earnings cycle; both are exposed to the same investor question of whether AI features are additive or merely defensive. If CRM cannot re-accelerate, these names can underperform by another 5-10% on multiple compression.
• For tactical upside, consider a small CRM put spread 4-8 weeks out rather than outright short stock. This captures the thesis that the guidance miss matters more than the quarter, while limiting squeeze risk if the market is already heavily de-risked.
• Watch for a catalyst reset in 6-12 weeks: if CRM shows conversion of Agentforce into RPO or higher cRPO, cover shorts quickly. That would be the first evidence that AI is moving from narrative to measurable demand.